These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2256192)

  • 1. High-dose epirubicin-cisplatin chemotherapy for advanced soft tissue sarcoma.
    Jelić S; Vuletić L; Milanović N; Tomasević Z; Kovcin V
    Tumori; 1990 Oct; 76(5):467-71. PubMed ID: 2256192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised study of high-dose epirubicin versus high-dose epirubicin-cisplatin chemotherapy for advanced soft tissue sarcoma.
    Jelić S; Kovcin V; Milanović N; Babović N; Kreacić M; Ristović Z; Vlajić M; Filipović-Ljesković I
    Eur J Cancer; 1997 Feb; 33(2):220-5. PubMed ID: 9135492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epirubicin 150 mg/m2-cisplatin versus epirubicin 180 mg/m2-cisplatin for advanced soft tissue sarcoma.
    Jelić S; Babović N; Kreacić M; Matković S; Milanović N; Gavrilović D; Tomasević Z
    Int J Clin Pharmacol Res; 1999; 19(4):129-38. PubMed ID: 10939030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II study of dose-intense ifosfamide plus epirubicin with hematopoietic growth factors for the treatment of patients with advanced soft tissue sarcomas; a novel sequential schedule.
    Serrone L; Zeuli M; Gamucci T; Nardi M; Cognetti F
    Cancer Chemother Pharmacol; 2001 Mar; 47(3):206-10. PubMed ID: 11320663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epirubicin and DTIC (EDIC) for advanced soft-tissue sarcomas.
    Lopez M; Carpano S; Di Lauro L; Vici P; Conti EM
    Oncology; 1991; 48(3):230-3. PubMed ID: 2023703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epirubicin and ifosfamide in advanced soft tissue sarcoma: a phase II study.
    Chevallier B; Leyvraz S; Olivier JP; Fargeot P; Facchini T; Vo Van ML
    Cancer Invest; 1993; 11(2):135-9. PubMed ID: 8462014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of epirubicin in advanced soft tissue sarcoma.
    Chevallier B; Montcuquet P; Fachini T; Nguyen Bui B; Kerbrat P; Bastit P; Vo Van ML
    Bull Cancer; 1990; 77(10):991-5. PubMed ID: 2249019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epirubicin and ifosfamide in advanced soft tissue sarcomas.
    Frustaci S; Foladore S; Buonadonna A; De Paoli A; Crivellari D; Carbone A; Sorio R; Morassut S; Monfardini S
    Ann Oncol; 1993 Sep; 4(8):669-72. PubMed ID: 8240997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A pilot study of high-dose zorubicin in advanced stages of soft tissue sarcoma in adults].
    Jelić S; Tomasević Z; Kreacić M; Kovcin V; Radosavljević D; Vlajić M
    Bull Cancer; 1996 Dec; 83(12):1002-7. PubMed ID: 9116363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of efficacy and toxicity of first line chemotherapy with or without epirubicin for patients with advanced stage soft tissue sarcoma.
    Cao J; Huang XE; Liu J; Wu XY; Lu YY
    Asian Pac J Cancer Prev; 2013; 14(12):7171-7. PubMed ID: 24460271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 107 consecutive patients with limited- and extensive-stage non-small-cell lung cancer.
    Fetscher S; Brugger W; Engelhardt R; Kanz L; Hasse J; Frommhold H; Wenger M; Lange W; Mertelsmann R
    Ann Oncol; 1997 Jan; 8(1):57-64. PubMed ID: 9093708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ifosfamide plus epirubicin at escalating doses in the treatment of locally advanced and/or metastatic sarcomas.
    Toma S; Palumbo R; Canavese G; Albanese E; Cantoni E; Barisone A; Reggiardo G; Rosso R; Santi L
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S222-7. PubMed ID: 8453703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of soft tissue sarcomas in the adult with a combination of vindesine and cisplatin with doxorubicin or epirubicin: a pilot study].
    Becouarn Y; Bui BN; Kerbrat P; Chauvergne J; Brunet R; Robert J
    Bull Cancer; 1987; 74(2):109-16. PubMed ID: 3475140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epirubicin or epirubicin and cisplatin as first-line therapy in advanced breast cancer. A phase III study.
    Nielsen D; Dombernowsky P; Larsen SK; Hansen OP; Skovsgaard T
    Cancer Chemother Pharmacol; 2000; 46(6):459-66. PubMed ID: 11138459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy with cisplatin, epirubicin and docetaxel in transitional cell urothelial cancer. Phase II trial.
    Pectasides D; Visvikis A; Aspropotamitis A; Halikia A; Karvounis N; Dimitriadis M; Athanassiou A
    Eur J Cancer; 2000 Jan; 36(1):74-9. PubMed ID: 10741298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II multicentre study of efficacy and feasibility of dose-intensified preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) in resectable gastroesophageal cancer.
    Jary M; Ghiringhelli F; Jacquin M; Fein F; Nguyen T; Cleau D; Nerich V; El Gani M; Mathieu P; Valmary-Degano S; Arnould L; Lassabe C; Lamfichekh N; Fratté S; Paget-Bailly S; Bonnetain F; Borg C; Kim S
    Cancer Chemother Pharmacol; 2014 Jul; 74(1):141-50. PubMed ID: 24824852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study of a rapid etoposide-cisplatin regimen in paediatric soft tissue sarcomas.
    Phillips MB; Pinkerton CR
    Eur J Cancer; 1992; 28(2-3):399-403. PubMed ID: 1591053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A combination chemotherapy with adriamycin, cyclophosphamide and DTIC (ACD) for advanced adult soft part sarcoma].
    Ikeda K; Ogawa M; Inagaki J; Horikoshi N; Inoue K; Usui N; Nakada H; Adachi K; Okada Y
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):235-9. PubMed ID: 6696459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study of rapidly alternating epirubicin/dacarbazine and ifosfamide as first-line therapy for metastatic soft-tissue sarcoma in adults.
    Harstrick A; Bokemeyer C; Schmoll HJ; Köhne-Wömpner CH; Knipp H; Schöffski P; Anagnou J; Wipperman B; Neumann S; Poliwoda H
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S217-21. PubMed ID: 8453702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-intense phase II study of weekly cisplatin and epidoxorubicin plus medroxyprogesterone acetate and recombinant interleukin 2 in stage IIIB-IV non-small cell lung cancer.
    Mantovani G; Macciò A; Mulas C; Massa E; Madeddu C; Mura L; Contu P; Versace R
    Oncol Rep; 2002; 9(3):661-70. PubMed ID: 11956647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.